A single-judge bench of Delhi high court had allowed Dr Reddy’s to continue manufacturing and exporting semaglutide to non-patent jurisdictions, while restraining domestic sales until the patent expires in March 2026.
Delhi HC reserves order on Novo’s plea against Dr Reddy’s semaglutide exports
📅 Published: January 19, 2026 |
📂 Category: Uncategorized
